Filter by last updated date
Showing 1 to 10 of 20
| Title | Reference number | Reference number sort | Published | Published date sort | Last updated | Last updated sort |
|---|---|---|---|---|---|---|
| Chemotherapy dose standardisation | Reference number:KTT22 | KTT00022 | Published:February 2018 | 20180201 | Last updated:February 2018 | 20180228 |
| Multimorbidity and polypharmacy | Reference number:KTT18 | KTT00018 | Published:January 2017 | 20170101 | Last updated:February 2018 | 20180218 |
| Psychotropic medicines in people with learning disabilities whose behaviour challenges | Reference number:KTT19 | KTT00019 | Published:January 2017 | 20170101 | Last updated:February 2018 | 20180218 |
| Safer insulin prescribing | Reference number:KTT20 | KTT00020 | Published:January 2017 | 20170101 | Last updated:February 2018 | 20180218 |
| Medicines optimisation in long-term pain | Reference number:KTT21 | KTT00021 | Published:January 2017 | 20170101 | Last updated:February 2018 | 20180218 |
| Biosimilar medicines | Reference number:KTT15 | KTT00015 | Published:February 2016 | 20160201 | Last updated:February 2018 | 20180218 |
| Anticoagulants, including non-vitamin K antagonist oral anticoagulants (NOACs) | Reference number:KTT16 | KTT00016 | Published:February 2016 | 20160201 | Last updated:February 2018 | 20180218 |
| Acute kidney injury (AKI): use of medicines in people with or at increased risk of AKI | Reference number:KTT17 | KTT00017 | Published:February 2016 | 20160201 | Last updated:February 2018 | 20180218 |
| Type 2 diabetes mellitus: medicines optimisation priorities | Reference number:KTT12 | KTT00012 | Published:January 2015 | 20150101 | Last updated:February 2018 | 20180218 |
| Non-steroidal anti-inflammatory drugs | Reference number:KTT13 | KTT00013 | Published:January 2015 | 20150101 | Last updated:February 2018 | 20180218 |